Isotopia Molecular Imaging
Isotopia aspired to be the world leader and innovative company in nuclear medicine by providing meaningful medical care for patients globally.
Diagnostic and therapeutic radioactive isotopes and cold kits
Our flagship product, the radioisotope Lutetium-177 (both C.A and N.C.A), has attracted considerable attention and exhibited great promise in treating a variety of late-stage cancers, including metastatic prostate cancer and neuroendocrine tumours.
A committed group of experts along with diverse production facilities
Our production facilities include an advanced nuclear pharmacy that provides radionuclide labeled compounds for PET/SPECT imaging, a cyclotron facility, and an aseptic manufacturing plant that also offers contract manufacturing services (CMO).
Guidance, support, and peace of mind
Our customer services are available round the clock to provide thorough and meticulous guidance and support.
Furthering our global presence
Ensuring our services are efficiently available globally, we established 3 production facilities in Israel, North America, and Europe for the secure supply of Lutetium-177 N.C.A
As we continue to take big strides towards becoming a prominent global supplier to the radiopharmaceutical industry, while maintaining the personal touch of a local partner, we remain focused on fulfilling the promise of nuclear medicine for advanced personalized cancer care.
Brands: Lu-177 n.c.a, Lu-177 c.a, isoPROtrace-11® - PSMA Cold kit
Lutetium 177 weekly supply by Isotopia Molecular Imaging
isoPROtrace-11 kit Tutorial